Pri-Med Workshop - Local, Clinical Application of GLP-1 Receptor Agonists: Patient selection and clinical use of Byetta ▼ (exenatide), Manchester
Tuesday, 16 November 2010
Below is an outline of the meeting. For more details about each session please select the Programme link from the left menu. This meeting is developed and sponsored by Lilly Diabetes.
Sessions
- The Rationale and Controversies Surrounding the Current Paradigm for the Treatment of Type 2 Diabetes
- GLP -1 Receptor Agonist Based Therapy
- Practicalities for General Practice
- Interactive Case Studies: Appropriate Assessment and Patient Selection
Bookmark & Share
Facebook
StumbleUpon
Windows Live
DiggDisclaimer
Click here to access the abbreviated prescribing information for Byetta (exenatide).
UKBYT00702 August 2010